Patients with or without CKD were comparable for factors that might potentially modify PAI‐1 expression, such as active cancer, metabolic syndrome, obesity, anticoagulant therapy, or renin–angiotensin system blockers (Table 4). This evidence concerns the gene REN and obesity disorder.